WINTON GROUP Ltd Buys Shares of 86,136 Oscar Health, Inc. (NYSE:OSCR)

WINTON GROUP Ltd purchased a new position in Oscar Health, Inc. (NYSE:OSCR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 86,136 shares of the company’s stock, valued at approximately $1,363,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. American International Group Inc. grew its position in shares of Oscar Health by 1.3% during the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after acquiring an additional 1,009 shares during the period. Arizona State Retirement System grew its stake in Oscar Health by 3.7% during the second quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after acquiring an additional 1,351 shares in the last quarter. ProShare Advisors LLC grew its position in shares of Oscar Health by 10.9% during the first quarter. ProShare Advisors LLC now owns 28,950 shares of the company’s stock valued at $430,000 after purchasing an additional 2,842 shares in the last quarter. Oppenheimer & Co. Inc. grew its holdings in Oscar Health by 20.8% during the 1st quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company’s stock valued at $289,000 after buying an additional 3,350 shares in the last quarter. Finally, Avalon Trust Co bought a new stake in Oscar Health in the first quarter worth $69,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 68,978 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the sale, the chief financial officer now owns 884,213 shares in the company, valued at approximately $15,906,991.87. The disclosure for this sale can be found here. Insiders sold 169,569 shares of company stock valued at $3,007,069 in the last three months. 25.11% of the stock is owned by insiders.

Oscar Health Stock Performance

Shares of OSCR stock opened at $21.61 on Monday. Oscar Health, Inc. has a 12-month low of $4.72 and a 12-month high of $23.44. The business’s fifty day simple moving average is $17.27 and its 200-day simple moving average is $17.34. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The company has a market cap of $5.13 billion, a PE ratio of -54.03, a PEG ratio of 40.95 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.04. The company had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The firm’s quarterly revenue was up 44.6% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.07) EPS. Analysts expect that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

OSCR has been the topic of several recent research reports. Wells Fargo & Company increased their price target on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Wednesday, June 12th. Bank of America restated a “neutral” rating and issued a $21.00 price objective (down from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Baird R W raised Oscar Health to a “strong-buy” rating in a research report on Thursday, May 30th. Piper Sandler reissued an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, Robert W. Baird assumed coverage on Oscar Health in a research note on Thursday, May 30th. They set an “outperform” rating and a $28.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $24.17.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.